1,004 reports of this reaction
13.9% of all CROMOLYN SODIUM reports
#1 most reported adverse reaction
TREATMENT FAILURE is the #1 most commonly reported adverse reaction for CROMOLYN SODIUM, manufactured by Prestige Brands Holdings, Inc.. There are 1,004 FDA adverse event reports linking CROMOLYN SODIUM to TREATMENT FAILURE. This represents approximately 13.9% of all 7,214 adverse event reports for this drug.
Patients taking CROMOLYN SODIUM who experience treatment failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TREATMENT FAILURE is a frequently reported adverse event for CROMOLYN SODIUM, accounting for a significant proportion of all reports.
In addition to treatment failure, the following adverse reactions have been reported for CROMOLYN SODIUM:
The following drugs have also been linked to treatment failure in FDA adverse event reports:
TREATMENT FAILURE has been reported as an adverse event in 1,004 FDA reports for CROMOLYN SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
TREATMENT FAILURE accounts for approximately 13.9% of all adverse event reports for CROMOLYN SODIUM, making it one of the most commonly reported side effect.
If you experience treatment failure while taking CROMOLYN SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.